Kiplinger Letter, The - Five new prescription drugs are nearing approval from the FDA.(HEALTH)
Five new prescription drugs are nearing approval from the FDA. All are potential blockbusters, helping drug firms replace profits lost because of expired patents on Zocor, Ambien and other popular drugs.
Related Results
Cheyenne, Wyo.-area doctors skeptical of ’super bill’ for weight loss, smoking.
Pounds-off prescription
Blockbuster obesity drug aims to win $4bn sales for Sanofi-Aventis
Obesity drug ‘to make a splash’.(Sanofi-Aventis)
Long-Term Benefits of Rimonabant Confirmed in Two-Year Study.
Awaiting the nod this year or next: A cervical cancer vaccine, Cervarix, from GlaxoSmithKline. An obesity-fighting drug, Acomplia, from Sanofi-Aventis. It blocks signals to …
Read the rest of this article with a Free Trial at HighBeam Research.